Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315 in Healthy Adult Volunteers Under Fasting Conditions
Latest Information Update: 03 Oct 2024
At a glance
- Drugs DWC 202315 (Primary) ; DWJ 1589 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Daewoong Pharmaceutical
- 26 Sep 2024 New trial record